In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

L. M. 'T Hart; A. Fritsche; G. Nijpels; N. Van Leeuwen; L. A. Donnelly; J. M. Dekker; M. Alssema; J. Fadista; F. Carlotti; A. P. Gjesing; C. N. Palmer; T. W. Van Haeften; S. A. Herzberg-Schäfer; A. M. Simonis-Bik; J. J. Houwing-Duistermaat; Q. Helmer; J. Deelen; B. Guigas; T. Hansen; F. MacHicao; G. Willemsen; R. J. Heine; M. H. Kramer; J. J. Holst; E. J. De Koning; H. U. Häring; O. Pedersen; L. Groop; E. J. De Geus; P. E. Slagboom; D. I. Boomsma; E. M. Eekhoff; E. R. Pearson; M. Diamant

doi:10.1089/dia.2015.1514

In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

L. M. 'T Hart, A. Fritsche, G. Nijpels, N. Van Leeuwen, L. A. Donnelly, J. M. Dekker, M. Alssema, J. Fadista, F. Carlotti, A. P. Gjesing, C. N. Palmer, T. W. Van Haeften, S. A. Herzberg-Schäfer, A. M. Simonis-Bik, J. J. Houwing-Duistermaat, Q. Helmer, J. Deelen, B. Guigas, T. Hansen, F. MacHicaoG. Willemsen, R. J. Heine, M. H. Kramer, J. J. Holst, E. J. De Koning, H. U. Häring, O. Pedersen, L. Groop, E. J. De Geus, P. E. Slagboom, D. I. Boomsma, E. M. Eekhoff, E. R. Pearson, M. Diamant

Original language	English
Journal	Diabetes Technology & Therapeutics
Volume	17
Pages (from-to)	S131-S133
ISSN	1520-9156
DOIs	https://doi.org/10.1089/dia.2015.1514
Publication status	Published - 1 Feb 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/dia.2015.1514

Cite this

'T Hart, L. M., Fritsche, A., Nijpels, G., Van Leeuwen, N., Donnelly, L. A., Dekker, J. M., Alssema, M., Fadista, J., Carlotti, F., Gjesing, A. P., Palmer, C. N., Van Haeften, T. W., Herzberg-Schäfer, S. A., Simonis-Bik, A. M., Houwing-Duistermaat, J. J., Helmer, Q., Deelen, J., Guigas, B., Hansen, T., ... Diamant, M. (2015). In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus. Diabetes Technology & Therapeutics, 17, S131-S133. https://doi.org/10.1089/dia.2015.1514

'T Hart, LM, Fritsche, A, Nijpels, G, Van Leeuwen, N, Donnelly, LA, Dekker, JM, Alssema, M, Fadista, J, Carlotti, F, Gjesing, AP, Palmer, CN, Van Haeften, TW, Herzberg-Schäfer, SA, Simonis-Bik, AM, Houwing-Duistermaat, JJ, Helmer, Q, Deelen, J, Guigas, B, Hansen, T, MacHicao, F, Willemsen, G, Heine, RJ, Kramer, MH, Holst, JJ, De Koning, EJ, Häring, HU, Pedersen, O, Groop, L, De Geus, EJ, Slagboom, PE, Boomsma, DI, Eekhoff, EM, Pearson, ER & Diamant, M 2015, 'In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus', Diabetes Technology & Therapeutics, vol. 17, pp. S131-S133. https://doi.org/10.1089/dia.2015.1514

@article{07fc7d0c394c40828fed36b74d77e54d,

title = "In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus",

author = "{'T Hart}, {L. M.} and A. Fritsche and G. Nijpels and {Van Leeuwen}, N. and Donnelly, {L. A.} and Dekker, {J. M.} and M. Alssema and J. Fadista and F. Carlotti and Gjesing, {A. P.} and Palmer, {C. N.} and {Van Haeften}, {T. W.} and Herzberg-Sch{\"a}fer, {S. A.} and Simonis-Bik, {A. M.} and Houwing-Duistermaat, {J. J.} and Q. Helmer and J. Deelen and B. Guigas and T. Hansen and F. MacHicao and G. Willemsen and Heine, {R. J.} and Kramer, {M. H.} and Holst, {J. J.} and {De Koning}, {E. J.} and H{\"a}ring, {H. U.} and O. Pedersen and L. Groop and {De Geus}, {E. J.} and Slagboom, {P. E.} and Boomsma, {D. I.} and Eekhoff, {E. M.} and Pearson, {E. R.} and M. Diamant",

year = "2015",

month = feb,

day = "1",

doi = "10.1089/dia.2015.1514",

language = "English",

volume = "17",

pages = "S131--S133",

journal = "Diabetes Technology & Therapeutics",

issn = "1520-9156",

publisher = "Mary AnnLiebert, Inc. Publishers",

}

TY - JOUR

T1 - In vivo efficacy of HD0471953

T2 - A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

AU - 'T Hart, L. M.

AU - Fritsche, A.

AU - Nijpels, G.

AU - Van Leeuwen, N.

AU - Donnelly, L. A.

AU - Dekker, J. M.

AU - Alssema, M.

AU - Fadista, J.

AU - Carlotti, F.

AU - Gjesing, A. P.

AU - Palmer, C. N.

AU - Van Haeften, T. W.

AU - Herzberg-Schäfer, S. A.

AU - Simonis-Bik, A. M.

AU - Houwing-Duistermaat, J. J.

AU - Helmer, Q.

AU - Deelen, J.

AU - Guigas, B.

AU - Hansen, T.

AU - MacHicao, F.

AU - Willemsen, G.

AU - Heine, R. J.

AU - Kramer, M. H.

AU - Holst, J. J.

AU - De Koning, E. J.

AU - Häring, H. U.

AU - Pedersen, O.

AU - Groop, L.

AU - De Geus, E. J.

AU - Slagboom, P. E.

AU - Boomsma, D. I.

AU - Eekhoff, E. M.

AU - Pearson, E. R.

AU - Diamant, M.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84923101546&partnerID=8YFLogxK

U2 - 10.1089/dia.2015.1514

DO - 10.1089/dia.2015.1514

M3 - Comment/debate

AN - SCOPUS:84923101546

SN - 1520-9156

VL - 17

SP - S131-S133

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

ER -

In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

UN SDGs

Access to Document

Other files and links

Cite this